65106 Safety profile of Rezpegaldesleukin, A Selective Regulatory T-Cell-Inducing Interleukin-2 Conjugate, versus Placebo Based on Aggregate Safety Evaluation of 746 Subjects Enrolled Across 9 Studies
Saved in:
Published in | Journal of the American Academy of Dermatology Vol. 93; no. 3; p. AB294 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.09.2025
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0190-9622 |
---|---|
DOI: | 10.1016/j.jaad.2025.05.1165 |